Venmax Drugs and Pharmaceuticals Ltd

VENM.IN

$0.06

Closing

1D

YTD

Market cap

$317350

52 week high

$

52 week low

$

Volume

1,500

Check if the stock is halal

Unlock Industry-grade Shariah Compliance for global stocks. See results from 5 major Shariah standards: AAOIFI, S&P, DJIM, FTSE and MSCI.

We provide unparalleled value and service.
Screened by AAOIFI Certified Shariah Advisor & Auditor.

Get started from just $3.99/month

Market cap

$317350

Analysts' Rating

-

Price Target (Mean)

Unable to collect data for some field(s).

Total Analysts

0

P/E

Operating Margin

0.00%

Beta

Revenue Growth (Annual)

0.00%

52 week high

$

52 week low

$

Div. Yield

%

EPS Annual Growth

0.00

Note on Purification and Zakat

  • Purification and Zakat (for long-term investing) calculations are in USD per share and based on AAOIFI methodology. AAOIFI requires purification every financial period (e.g. quarterly). 
  • If you follow S&P Shariah’s Dividend-only purification, then remove the impure income % from the dividends you receive. No purification required for non-dividend paying stocks, according to S&P Shariah.
  • For Zakat, if you did not invest in a company from a long term perspective, then consider the shares as trading goods and give 2.5% of the total value if a year has passed on them. 

Company Profile

Venmax Drugs and Pharmaceuticals Limited is an India-based company. The Company is primarily engaged in the manufacturing and sale of bulk drugs. The Company operates through the drug segment. The company is developing the oncology products through research and development (R&D).